Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.

<h4>Background and aim</h4>Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nucle...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aloysious Aravinthan, Giada Pietrosi, Matthew Hoare, James Jupp, Aileen Marshall, Clare Verrill, Susan Davies, Adrian Bateman, Nick Sheron, Michael Allison, Graeme J M Alexander
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f7baa89d77754508aaf5a78aa3fd829b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f7baa89d77754508aaf5a78aa3fd829b
record_format dspace
spelling oai:doaj.org-article:f7baa89d77754508aaf5a78aa3fd829b2021-11-18T08:54:01ZHepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.1932-620310.1371/journal.pone.0072904https://doaj.org/article/f7baa89d77754508aaf5a78aa3fd829b2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24086266/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background and aim</h4>Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD.<h4>Methods</h4>Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively.<h4>Results</h4>In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation.<h4>Conclusions</h4>The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD.Aloysious AravinthanGiada PietrosiMatthew HoareJames JuppAileen MarshallClare VerrillSusan DaviesAdrian BatemanNick SheronNick SheronMichael AllisonGraeme J M AlexanderPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e72904 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Aloysious Aravinthan
Giada Pietrosi
Matthew Hoare
James Jupp
Aileen Marshall
Clare Verrill
Susan Davies
Adrian Bateman
Nick Sheron
Nick Sheron
Michael Allison
Graeme J M Alexander
Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.
description <h4>Background and aim</h4>Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD.<h4>Methods</h4>Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively.<h4>Results</h4>In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation.<h4>Conclusions</h4>The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD.
format article
author Aloysious Aravinthan
Giada Pietrosi
Matthew Hoare
James Jupp
Aileen Marshall
Clare Verrill
Susan Davies
Adrian Bateman
Nick Sheron
Nick Sheron
Michael Allison
Graeme J M Alexander
author_facet Aloysious Aravinthan
Giada Pietrosi
Matthew Hoare
James Jupp
Aileen Marshall
Clare Verrill
Susan Davies
Adrian Bateman
Nick Sheron
Nick Sheron
Michael Allison
Graeme J M Alexander
author_sort Aloysious Aravinthan
title Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.
title_short Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.
title_full Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.
title_fullStr Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.
title_full_unstemmed Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.
title_sort hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/f7baa89d77754508aaf5a78aa3fd829b
work_keys_str_mv AT aloysiousaravinthan hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT giadapietrosi hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT matthewhoare hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT jamesjupp hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT aileenmarshall hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT clareverrill hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT susandavies hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT adrianbateman hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT nicksheron hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT nicksheron hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT michaelallison hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
AT graemejmalexander hepatocyteexpressionofthesenescencemarkerp21islinkedtofibrosisandanadverseliverrelatedoutcomeinalcoholrelatedliverdisease
_version_ 1718421239619387392